THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN INVITATION OR OFFER TO SELL OR THE SOLICITATION OF AN INVITATION OR OFFER TO BUY ANY SECURITY. NONE OF THE SECURITIES REFERRED TO IN THIS ANNOUNCEMENT SHALL BE SOLD, ISSUED, SUBSCRIBED FOR, PURCHASED, EXCHANGED OR TRANSFERRED IN ANY JURISDICTION IN CONTRAVENTION OF APPLICABLE LAW
28 January 2015
Assura plc
Admission of Assura plc shares
Further to the announcement issued by Assura Group Limited on 27 January 2015, confirming the Court approval of the Scheme, Assura plc and Assura Group Limited are pleased to confirm that the Scheme is now effective and Assura plc is now the new parent company of the Assura Group.
The Scheme became effective at 8.00 a.m. today and accordingly the Assura Group Limited shares were delisted from the premium segment of the Official List of the UK Listing Authority and from the London Stock Exchange's main market with effect from 8.00 a.m. today.
Admission of the Assura plc shares to the premium listing segment of the Official List of the UK Listing Authority and admission to trading on the London Stock Exchange's main market also took effect at 8.00 a.m. today.
Under the Scheme, Scheme Shareholders received one Assura plc share for every share in Assura Group Limited held by them at the Scheme Record Time. Therefore, the total issued ordinary share capital of Assura plc is 1,006,900,141 ordinary shares of 10 pence each.
The new ISIN number for Assura plc shares is GB00BVGBWW93. Assura plc has the same TIDM as Assura Group Limited, which will remain as "AGR".
CREST accounts will be credited with Assura plc shares today and share certificates in respect of Assura plc shares will be dispatched within 7 business days of today.
Capitalised terms, unless otherwise defined in this announcement, have the meaning given to them in the circular published by Assura Group Limited on 17 December 2014.
A copy of this announcement will be made available on Assura plc's website (www.assuragroup.co.uk (which is also the website for Assura Group Limited)).
For more information, please contact:
Assura plc |
Tel: 01925 420660 |
Jonathan Murphy Carolyn Jones |
|
Finsbury |
Tel: 0207 251 3801 |
Gordon Simpson |
|
This announcement may contain certain forward-looking statements. These forward looking statements include all matters that are not historical facts. These forward looking statements involve risks and uncertainties that could cause the actual results of operations, financial condition, prospects and the development of the sector in which Assura operates to differ materially from the impression created by these forward-looking statements. Assura does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Do not place undue reliance on forward-looking statements, which speak only as of the date of this document.
Notes to Editors
Assura is a long-term investor in and developer of primary care property. The company, headquartered in Warrington and listed on the London Stock Exchange, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 30 September 2014, Assura's property portfolio was valued at £809m.
Further information is available at www.assuragroup.co.uk.
-Ends-